Patents by Inventor Aisha Naeem

Aisha Naeem has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENHANCING CHEMOTHERAPY IN MEDULLOBLASTOMA AND GLIOBLASTOMA WITH HIGH BASAL p53 LEVELS
    Publication number: 20240058421
    Abstract: Provided herein is a method of treating medulloblastoma or glioblastoma in a subject by administering to the subject a PI3K activator (e.g., thymosin ?-4 or a derivative thereof) and one or more chemotherapeutic agents and/or radiation. The combination therapy is effective in the treatment of medulloblastoma or glioblastoma characterized by cells with elevated p53 levels.
    Type: Application
    Filed: October 13, 2023
    Publication date: February 22, 2024
    Applicant: GEORGETOWN UNIVERSITY
    Inventors: Christopher ALBANESE, Aisha NAEEM
  • Enhancing chemotherapy in medulloblastoma and glioblastoma with high basal p53 levels
    Patent number: 11896650
    Abstract: Provided herein is a method of treating medulloblastoma or glioblastoma in a subject by administering to the subject a PI3K activator (e.g., thymosin ?-4 or a derivative thereof) and one or more chemotherapeutic agents and/or radiation. The combination therapy is effective in the treatment of medulloblastoma or glioblastoma characterized by cells with elevated p53 levels.
    Type: Grant
    Filed: March 24, 2022
    Date of Patent: February 13, 2024
    Assignee: GEORGETOWN UNIVERSITY
    Inventors: Christopher Albanese, Aisha Naeem
  • ENHANCING CHEMOTHERAPY IN MEDULLOBLASTOMA AND GLIOBLASTOMA WITH HIGH BASAL p53 LEVELS
    Publication number: 20220241379
    Abstract: Provided herein is a method of treating medulloblastoma or glioblastoma in a subject by administering to the subject a PI3K activator (e.g., thymosin ?-4 or a derivative thereof) and one or more chemotherapeutic agents and/or radiation. The combination therapy is effective in the treatment of medulloblastoma or glioblastoma characterized by cells with elevated p53 levels.
    Type: Application
    Filed: March 24, 2022
    Publication date: August 4, 2022
    Applicant: GEORGETOWN UNIVERSITY
    Inventors: Christopher ALBANESE, Aisha NAEEM
  • Enhancing chemotherapy in medulloblastoma and glioblastoma with high basal p53 levels
    Patent number: 11311606
    Abstract: Provided herein is a method of treating medulloblastoma or glioblastoma in a subject by administering to the subject a PI3K activator (e.g., thymosin ?-4 or a derivative thereof) and one or more chemotherapeutic agents and/or radiation. The combination therapy is effective in the treatment of medulloblastoma or glioblastoma characterized by cells with elevated p53 levels.
    Type: Grant
    Filed: March 12, 2019
    Date of Patent: April 26, 2022
    Assignee: GEORGETOWN UNIVERSITY
    Inventors: Christopher Albanese, Aisha Naeem
  • ENHANCING CHEMOTHERAPY IN MEDULLOBLASTOMA AND GLIOBLASTOMA WITH HIGH BASAL p53 LEVELS
    Publication number: 20210244797
    Abstract: Provided herein is a method of treating medulloblastoma or glioblastoma in a subject by administering to the subject a PI3K activator (e.g., thymosin ?-4 or a derivative thereof) and one or more chemotherapeutic agents and/or radiation. The combination therapy is effective in the treatment of medulloblastoma or glioblastoma characterized by cells with elevated p53 levels.
    Type: Application
    Filed: March 12, 2019
    Publication date: August 12, 2021
    Applicant: GEORGETOWN UNIVERSITY
    Inventors: Christopher Albanese, Aisha Naeem